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Gcn4, a yeast transcriptional activator that promotes the expression of amino acid and purine
biosynthesis genes, is rapidly degraded in rich medium. Here we report that SCFCDC4, a recently
characterized protein complex that acts in conjunction with the ubiquitin-conjugating enzyme
Cdc34 to degrade cell cycle regulators, is also necessary for the degradation of the transcription
factor Gcn4. Degradation of Gcn4 occurs throughout the cell cycle, whereas degradation of the
known cell cycle substrates of Cdc34/SCFCDC4 is cell cycle regulated. Gcn4 ubiquitination and
degradation are regulated by starvation for amino acids, whereas the degradation of the cell cycle
substrates of Cdc34/SCFCDC4 is unaffected by starvation. We further show that unlike the cell
cycle substrates of Cdc34/SCFCDC4, which require phosphorylation by the kinase Cdc28, Gcn4
degradation requires the kinase Pho85. We identify the critical target site of Pho85 on Gcn4; a
mutation of this site stabilizes the protein. A specific Pho85-Pcl complex that is able to phosphor-
ylate Gcn4 on that site is inactive under conditions under which Gcn4 is stable. Thus, Cdc34/
SCFCDC4 activity is constitutive, and regulation of the stability of its various substrates occurs at
the level of their phosphorylation.
INTRODUCTION
Regulation of cellular processes occurs in a large measure
via modulation of steady-state levels of key regulatory pro-
teins. This modulation can occur not only at the level of their
synthesis but also at the level of their degradation. Gcn4, a
yeast transcriptional activator involved in biosynthesis of
amino acids and purines (Hinnebusch and Fink, 1983; Hope
and Struhl, 1985), is under this dual control. Starvation for
amino acids leads to an increase in Gcn4 translation (Hin-
nebusch, 1984), which in turn induces the transcription of
amino acid biosynthetic genes, thereby providing the nutri-
ents that were formerly limiting for growth. The levels of
Gcn4 protein are controlled both at the level of synthesis and
degradation. Gcn4 synthesis is increased by a translational
control mechanism that involves phosphorylation of the
general translation initiation factor eIF-2a by the kinase
Gcn2 (Dever et al., 1992; for review, see Hinnebusch, 1997).
In addition, Gcn4 is degraded extremely rapidly; however,
under amino acid starvation conditions, Gcn4 is stabilized
(Kornitzer et al., 1994).
The ubiquitin system is the major cytoplasmic pathway by
which proteins are degraded (for a recent review, see
Hershko and Ciechanover, 1998). Target proteins are first
modified by the sequential addition of ubiquitin, a small,
conserved protein. Ubiquitinated proteins are then de-
graded by a large multicatalytic protease, the 26S protea-
some. Protein ubiquitination is catalyzed by a ubiquitin-
conjugating enzyme, which accepts a ubiquitin “activated”
as a thiolester by the ubiquitin-activating enzyme, and trans-
fers it to the e-amino group of an internal lysine on the target
protein (or to the a-amino group of the polypeptide chain;
Breitschopf et al., 1998). The transfer from the ubiquitin-
conjugating enzyme to the target requires a third compo-
nent, called ubiquitin ligase, which constitutes the main
recognition component of the system and in some cases may
form a second intermediate thiolester with ubiquitin.
Unlike the ubiquitin-conjugating enzymes, which carry a
distinctive sequence signature, ubiquitin ligases fall in a
number of groups with little sequence similarity. At least
four types of ligases can be distinguished, two of which
consist of large protein complexes (Hershko and Ciech-
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anover, 1998). These are the anaphase-promoting complex
(APC) or cyclosome (King et al., 1995; Sudakin et al., 1995)
and the SCF complex (Feldman et al., 1997; Skowyra et al.,
1997). The latter stands for Skp1-Cdc53 (or Cullin)-F box
protein complex, in which the F-box protein constitutes a
variable component that is thought to define the target spec-
ificity of the complex (for review, see Patton et al., 1998b). A
fourth component of the SCF complex, Rbx1, recently was
discovered (Kamura et al., 1999; Skowyra et al., 1999). The
SCF ubiquitin ligase is found to interact with a single type of
ubiquitin-conjugating enzyme, Cdc34 (Feldman et al., 1997;
Skowyra et al., 1997; Mathias et al., 1998). Targets of the
SCFCDC4 complex (the SCF complex containing Cdc4 as the
F-box component) in yeast that have been identified so far
include the cyclin-dependent kinase (CDK) inhibitors Sic1
(Feldman et al., 1997) and Far1 (Henchoz et al., 1997) and the
DNA replication regulator Cdc6 (Drury et al., 1997; Elsasser
et al., 1999; Sanchez et al., 1999). Other yeast SCF complexes
were found to target other substrates, such as Cln1 and -2
and Gic2 (SCFGRR1; Skowyra et al., 1997; Jaquenoud et al.,
1998; Patton et al., 1998a) and the inhibitory kinase Swe1
(SCFMET30; Kaiser et al., 1998). In mammalian cells, a specific
SCF complex, SCFb-TrCP, recently was found to target IkB for
ubiquitination (Yaron et al., 1998; Spencer et al., 1999; Win-
ston et al., 1999). Unlike APC substrates, which contain a
consensus sequence required for degradation (the “destruc-
tion box”; Yamano et al., 1996), no such consensus has been
found yet for the SCF substrates. However, common to
many, and perhaps all, instances of ubiquitination by SCF
complexes is the requirement for phosphorylation of the
substrate (Hershko and Ciechanover, 1998). In yeast, ubiq-
uitination of the CDK inhibitors Sic1 and Far1 and of the
DNA replication regulator Cdc6 were shown to require ac-
tivity of the major yeast cell cycle CDK, Cdc28 (Henchoz et
al., 1997; Verma et al., 1997; Elsasser et al., 1999). A second
yeast CDK, Pho85, which is not essential for cell cycle pro-
gression, recently was found to be also capable of phosphor-
ylating Sic1 (Nishizawa et al., 1998).
Previous work has shown that Gcn4 is degraded via the
ubiquitin system and stabilized in proteasome mutants, as
well as in a mutant of the ubiquitin-conjugating enzyme
Cdc34 (Kornitzer et al., 1994). However, neither the precise
ubiquitination complex required for Gcn4 degradation nor
the mechanism of regulation of Gcn4 degradation by star-
vation had been defined. Here we show that degradation of
Gcn4 requires the kinase Pho85 and the SCFCDC4 ubiquitin–
ligase complex. Our data indicate that Pho85 activity is
repressed by starvation and suggest that the targeting of
Gcn4 to the ubiquitin–ligase complex SCFCDC4 is deter-
mined by a specific Pho85-mediated phosphorylation event.
MATERIALS AND METHODS
Plasmids and Strains
The CUP1 vector plasmid KB354 was constructed by cloning the
BamHI–EcoRI CUP1 promoter fragment from plasmid pYSK7 (Butt
et al., 1984) to pRS314 (Sikorski and Hieter, 1989), followed by
deletion of the SacII–BamHI sequence of the polylinker. PCR cloning
(Ausubel et al., 1989) was used to fuse the coding sequence of GCN4
to the CUP1 promoter of KB354. The resulting plasmid was then
digested with BamHI and HindIII to generate a fragment carrying
part of the TRP1 sequence, the CUP1 promoter sequence, and the 59
end of the GCN4 sequence. This fragment was cloned in KB64
digested with the same enzymes, to generate a CUP1p–GCN4–LacZ
fusion (KB449). pGAL–CYC1–LacZ (KB496) was constructed by
inserting a PCR-generated BglII fragment carrying the whole GCN4
coding sequence into the BamHI site of plasmid pLGSD5 (from L.
Guarente, Massachusetts Institute of Technology). pGAL–CDC6–
LacZ (KB448) was constructed by substituting the GCN4 coding
region of plasmid KB64 (Kornitzer et al., 1994) with a PCR-generated
BamHI–EcoRI fragment carrying the CDC6 coding sequence. The
T165A mutation was introduced by site-directed mutagenesis into
the ADE8-GCN4 construct KB105 (Kornitzer et al., 1994), to generate
KB853. PCR cloning was used to subsequently transfer the mutation
to the pGAL–GCN4–LacZ plasmid KB149, to generate KB854. The
pCUP1–SIC1 plasmid (KB733) was generated by PCR cloning of an
EcoRI–SalI fragment carrying SIC1 into the pCUP1 vector KB354
digested with the same enzymes, to generate KB733. pGAL1–
CLN2(4T3S)HA expressing a stabilized version of Cln2 (Lanker et
al., 1996) was obtained from Curt Wittenberg (Scripps Research
Institute). The GCN4 deletion D(93–140) (KB 92) was described
previously (Kornitzer et al., 1994). The GCN4 deletion D(151–167)
fused to LacZ (KB295) was generated by digestion of the GCN4
coding sequence with KpnI and XbaI, filling-in, and religation. The
plasmid expressing the myc-tagged Gcn4(62–202) fragment was
constructed in two steps: first, PCR was used to generate an EcoRI
site and an initiation codon in front of the Gcn4(62–202)–encoding
fragment and an XhoI site preceded by a termination codon and a
BamHI site at the other end of the fragment (forward primer: 59
CCGAATTCATGTCGAACCTTGATTTTGATT; reverse primer: 59
GGCCTCGAGTTAGGATCCCATATGATCCAGTCTCGATTCG).
This fragment was then cloned in the EcoRI and XhoI sites of
plasmid KB354 to generate KB 885 (wild type) and KB 887 (T165A).
In a second step, a triple Myc-epitope–carrying BamHI fragment
(Kornitzer and Kron, unpublished results) was cloned into the
BamHI site of plasmids KB885 and KB887 to generate KB891 and
KB893, respectively. The GST-Gcn4(62–202)–expressing plasmid
was constructed by recloning the EcoRI-XhoI fragments of KB885
and KB887 into pGEX-4T-1 (Pharmacia Biotech, Piscataway, NJ) to
generate KB927 and KB928, respectively. The plasmid expressing
heptahistidine-tagged Gcn4 under the T7 promoter was constructed
by cloning a Gcn4-carrying PCR fragment into pET11-his7 (obtained
from S. Buratowski, Harvard Medical School) to generate KB363.
Plasmids pGEX-PHO85, pGEX-pho85(E53A), pGEX-PCL1, pGEX-
PHO80, and Yep-GAL10-HA-PCL1 are described in Nishizawa et al.
(1998).
The cdc4-1 strain (KY301) was constructed by homologous recom-
bination. The region extending from 2270 to 1 2575 relative to the
CDC4 start site was cloned by PCR from a cdc4-1 strain (Fink
laboratory collection) between the BamHI and EcoRI sites of plasmid
YIp5, to yield KB527. Strain KY289 (an a strain isogenic to KY204)
was transformed with KpnI-digested KB527, to yield a tandem
mutant–wild-type structure in the chromosome, separated by the
YIp5 sequence. Passage over 5-fluoroorotic acid to select for excision
of the URA3 sequence of Yip5 by homologous recombination
yielded a fraction of colonies in which the wild-type allele was
excised and the mutant retained in the chromosome. The
pho85D::hisG strain (DY4535) was constructed in several steps. First,
the PHO85 gene in a diploid W303 strain was replaced with a
pho85D::LEU2 allele using a disruption cassette provided by Brenda
Andrews (University of Toronto). A pho85D::LEU2 haploid strain
was derived from this diploid, and this was converted to a
pho85D::hisG-URA3-hisG allele using plasmid pNKY85 (Alani et al.,
1987). Finally, the strain with the pho85D::hisG allele was recovered
after passage over 5-fluoro-orotic acid medium. The other yeast
strains used and their origins are described in Table 1.
Degradation Assays
The pulse–chase experiments were performed essentially as de-
scribed previously (Kornitzer et al., 1994). Briefly, overnight cultures
were diluted in 10 ml and grown to midlog phase, washed two
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times with medium lacking methionine, concentrated to 0.3 ml, and
pulse-labeled for 5 min with 750–900 mCi [35S]methionine (“ex-
press,” NEN, Arlington, MA), pelleted again and chased in medium
containing 10 mM methionine and 10 mM cysteine. For the exper-
iments involving temperature-sensitive mutants, the cells were
shifted from 30 to 37°C 20–40 min before labeling. Similarly, for the
starvation studies, cells were harvested by centrifugation and
grown in SD medium 1 adenine for 15–45 min before labeling and
chased in the same medium 1 methionine and cysteine. At various
times of the chase, an aliquot of the culture was removed and
incubated 15 min on ice with 0.35 M NaOH and 1.5% 2-mercapto-
ethanol, followed by precipitation with 6% trichloroacetic acid. The
protein precipitate was resuspended by boiling in 2.5% SDS and 5
mM EDTA, and equal amounts of trichloroacetic acid–precipitable
radioactivity were immunoprecipitated in at least 10 volumes of
buffer A (Hochstrasser and Varshavsky, 1990) containing protein
A-Sepharose (Pharmacia). The immunoprecipitates were run on
SDS-polyacrylamide gels, and the protein bands were quantitated
using a Fujix Bas 2000 bioimage analyzer (Fuji, Tokyo, Japan).
Antibodies used were either monoclonal anti-myc (9E10; Kolodziej
and Young, 1991), anti-b-galactosidase (Cappel, Malvern, PA), or
anti-Gcn4, which were generated in rabbits injected with recombi-
nant GST-Gcn4 fusion protein. The proteins we tested were usually
ectopically expressed either from the GAL1 promoter of from the
CUP1 promoter. CUP1 is induced by copper ions; however, even in
the absence of copper, enough protein is produced to permit detec-
tion in pulse-labeling assays. The half-life of Gcn4 expressed from
the CUP1 promoter (Figures 1, 2A, 3, and 7A), 2–3 min, was some-
what shorter than that of the same protein expressed under the
GAL1 promoter (3–5 min; see Kornitzer et al. [1994] and Figures 2D,
6, and 8). This difference may be due to the difference in the carbon
source used (glucose vs. galactose). For the experiments performed
in cell cycle-arrested cells, 3 mM a-factor or 0.2 M hydroxyurea were
used to arrest cells in G1 and S, respectively. Cell cycle arrest was
monitored microscopically; the labeling was initiated after .90% of
the cells had arrested as unbudded or large-budded cells, respec-
tively.
In Vivo Phosphorylation Assay
For in vivo phosphate labeling, cells were grown overnight in yeast
nitrogen base (YNB) with the required amino acids and a reduced
KH2PO4 concentration (1 instead of 6 mM). The cells were then
diluted in the same medium but with 0.1 mM KH2PO4, grown to
optical density (OD)600 5 0.5, and treated with 1 mg/ml cyclohexi-
mide or transferred to YNB devoid of the required amino acids to
induce starvation, as required. Cells were then washed twice with
the same medium containing only 50 mM KH2PO4, and each sample
(5 OD units of cells) was labeled for 15 min in 0.5 ml of the same
medium containing 1 mCi 32PO4. Cell extract preparation and im-
munoprecipitation were performed as for the degradation assay.
Kinase Assays
For the in vitro kinase reactions with recombinant proteins, 10 ng
GST-PHO85,10 ng GST-cyclin, and 0.5 mg substrate were incubated
at 30°C for 30 min with 1 mCi [32P-g]ATP and 0.1 mM cold ATP in
10 ml kinase assay buffer (50 mM Tris, 10 mM MgCl2, 2 mM EDTA,
1 mM dithiothreitol, pH 7.5). Recombinant proteins were expressed
and purified according to standard protocols. An ultrafiltration
centrifugal device was used for buffer exchange and concentration
of the protein. For the immunoprecipitated kinase assays, extracts of
50 ml exponentially growing culture induced 4 h with galactose to
express ha-Pcl1 and starved or cycloheximide-treated as indicated
were made by breaking the cells for 5 min with glass beads in
extract buffer (50 mM Tris, pH 7.5, 250 mM NaCl, 5 mM EDTA, 0.5%
NP40, phosphatase inhibitors: 2 mM Na-pyrophosphate, 80 mM
b-glycerolphosphate, 10 mM NaF, 0.3 mM NaVO3, protease inhib-
itors: 2 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride,
aprotinin 1:100, TPCK 50 mg/ml, TLCK 50 mg/ml, and 1:500 of an
antiprotease cocktail containing leupeptin, pepstatin, and chymo-
statin, each 10 mg/ml in dimethyl sulfoxide). Five to 20 ml of 0.2 mg
protein extract were incubated with the 12CA5 monoclonal anti-
body for 30 min on ice and then 20 ml of a 50% slurry of protein
A-agarose beads (Pharmacia) and 200 ml extract buffer were added,
and the tubes were incubating while tumbling for 1 h at 4°C. The
agarose beads were then washed three times with extract buffer
lacking aprotinin, TPCK, TLCK, and the 5003 antiprotease cocktail,
and two times with kinase buffer. For each phosphorylation reac-
tion, the agarose bead pellet was incubated 20 min at 30°C with 0.2
mg substrate in 10 ml kinase buffer with 1 mCi [32P-g]ATP and 20 mM
cold ATP. All the kinase reactions were terminated by the addition
of 10 ml protein-loading buffer and electrophoresed on an SDS-
PAGE gel.
RESULTS
Inhibition of Translation Leads to Gcn4
Stabilization
Degradation of Gcn4 occurs through the ubiquitin pathway
and is inhibited under amino acid starvation conditions or in
Table 1. Yeast strains
Name Genotype Source
KY26 a ura3-52 leu2-D2 trp1-D1 bas1-2 bas2-2 gcn4-D1 Kornitzer et al. (1994)
KY204 KY26 ade8-GCN4 Kornitzer et al. (1994)
KY205 KY204 cdc34-2 Kornitzer et al. (1994)
KY301 KY204 cdc4-1 This work
W303-1A ura3-1 ade2-1 can1-100 leu2-3,112 trp1-1his3-11,15 R. Rothstein
DY4535 W303 pho85D<hisG This work
Y552 W303 skp1-11 Bai et al. (1996)
Y554 W303 skp1-12 Bai et al. (1996)
YPH1015 ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-D1
CFIII(CEN3.L.YPH983)-HIS3-SUP11
Connelly and Hieter (1996)
YPH1161 YPH1015 LEU2<skp1-4 Connelly and Hieter (1996)
YPH1172 YPH1015 LEU2<skp1-3 Connelly and Hieter (1996)
MTY668 W303 cdc4-1 M. Tyers
MTY670 W303 cdc34-2 M. Tyers
MTY740 W303 cdc53-1 Willems et al. (1996)
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an amino acyl-tRNA synthetase mutant (Kornitzer et al.,
1994). To define further the signal that inhibits Gcn4 degra-
dation, we examined the role of translation on Gcn4 degra-
dation. In previous pulse–chase experiments designed to
measure the rate of Gcn4 decay, we noticed that the addition
of the translational inhibitor cycloheximide at the beginning
of the chase typically reduced the rate of Gcn4 decay starting
10 min into the chase (see Kornitzer et al., 1994). To test the
possibility that inhibition of protein synthesis can reduce
Gcn4 turnover, Gcn4-expressing cells were preincubated
with 0.5 mg/ml cycloheximide, so as to reduce protein syn-
thesis by 80–90%. This pretreatment with the translation
inhibitor led to a complete stabilization of the protein (Fig-
ure 1). In a separate experiment, cycloheximide was added
to 0.1 mg/ml or the translational inhibitor paromomycin was
added to 10 mg/ml; under these conditions, translation was
inhibited twofold at most, and the half-life of Gcn4 was
increased twofold (our unpublished results).
Several SCF Components Are Implicated in Gcn4
Degradation
To clarify the regulatory mechanism of Gcn4 degradation,
we first attempted to identify the ubiquitin ligase required
for Gcn4 degradation. It was previously shown that Gcn4 is
stabilized in a cdc34 mutant (Kornitzer et al., 1994). We asked
whether mutants of the SCF complex would affect Gcn4
degradation. A Gcn4–LacZ fusion, previously shown to be
degraded with the same kinetics as native Gcn4 (Kornitzer et
al., 1994), was placed under the control of the CUP1 pro-
moter (see MATERIALS AND METHODS). The cdc4-1 mu-
tant displays a cell cycle arrest phenotype similar to that of
cdc34-2: both arrest at the G1 to S transition, with a mul-
Figure 1. Inhibition of translation stabilizes Gcn4. Gcn4–LacZ was
expressed from the CUP1 promoter of plasmid KB449. 1CHX: cells
were preincubated for 30 min in 0.5 mg/ml cycloheximide and then
labeled and chased in the presence of the drug. The arrow on the left
indicates Gcn4–LacZ.
Figure 2. Gcn4 degradation is inhibited in cdc34
and cdc4 mutants. (A) Pulse-and-chase analysis of
Gcn4–LacZ expressed from the CUP1 promoter of
plasmid KB449 in strains KY204, KY205, and KY301.
The cultures were shifted from 30 to 37°C, 20 min
before the labeling. (B) Quantitation of the experi-
ment shown in (A). (C) Fluorescence-activated cell
sorter analysis of cells at the time of labeling. (D)
Pulse–chase analysis of Gcn4–-LacZ expressed from
the GAL1 promoter of plasmid KB64 in a-factor–
arrested cells. Cells were arrested with a-factor at
the permissive temperature and then shifted to 37°
for 30 min before labeling.
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Molecular Biology of the Cell918
tibudded phenotype (Yochem and Byers, 1987). We tested
degradation of Gcn4 in cdc34-2 and cdc4-1 cells 20 min after
they were shifted up to the nonpermissive temperature of
37°C. As can be seen in Figure 2, the half-life of Gcn4 is
extended from 2.5 min to 12 and 20 min, respectively. We
also tested whether the F-box protein Grr1, which is re-
quired for the degradation of G1 cyclins (Barral et al., 1995;
Skowyra et al., 1997), is involved in Gcn4 degradation. No
effect was seen on the half-life of Gcn4 in strains carrying a
null allele of GRR1 (our unpublished results).
One concern is that the stabilization of Gcn4 in the cdc34
and cdc4 mutants may be an indirect consequence of their
cell cycle arrest rather than a direct consequence of their
function in the ubiquitin pathway. However, if Gcn4 degra-
dation were cell cycle dependent, then it should be biphasic
in a population of cycling cells. Because we find that in
cycling cells, Gcn4 degradation is exponential over two or-
ders of magnitude (e.g., see Figures 2 and 3), if there is a cell
cycle window where Gcn4 is stable, it has to be extremely
narrow. It is still possible in theory that the cdc34 and cdc4
mutants arrest in that window. To address this concern, we
analyzed the cell cycle distribution of the various strains at
the time of labeling. Although the mutant strains do display
a higher proportion of G1 cells than the wild-type strains
(see Figure 2C), fully one-third of the mutant cells were still
in G2/M at the time of labeling. Thus, the fact that cells in
different stages of the cell cycle show stabilization of Gcn4
argues against the stabilization being an indirect effect of cell
cycle arrest. This possibility was further addressed in an
alternative way: wild-type and cdc34 mutant cells expressing
Gcn4–LacZ under the GAL1,10 promoter were arrested in
G1 with a-factor, the cells were shifted to the nonpermissive
temperature, and Gcn4 degradation was assayed. As shown
in Figure 2D, the pattern of degradation was identical to that
in cycling cells (rapid in the wild type, very slow in the cdc34
mutant), demonstrating that the stabilization of Gcn4 is
unrelated to the cell cycle phenotype of cdc34.
Two other SCF components, Cdc53 and Skp1, were tested
for effects on Gcn4 degradation. The cdc53-1 mutant arrests
with the same cell cycle phenotype as cdc4 and cdc34
(Mathias et al., 1996). Pulse–chase analysis showed that
Gcn4 is strongly stabilized in cdc53-1, with an increase in the
half-life of the protein from 2 to 15 min (Figure 3). SKP1 was
isolated as a suppressor of cdc4-1 (Bai et al., 1996), and
various skp1 alleles arrest in either G1 or G2/M of the cell
cycle (Bai et al., 1996; Connelly and Hieter, 1996). We found
that, although the G1-arresting alleles skp1-3 (Figure 3) and
skp1-11 (our unpublished results) strongly stabilized Gcn4,
the effect of the G2-arresting alleles skp1-4 (Figure 3) and
skp1-12 (our unpublished results) was more moderate.
We next tested the effects of overexpression of Gcn4 in
wild-type versus mutant cells. Overexpression of Gcn4 leads
to slower growth of wild-type cells but does not involve an
obvious cell cycle delay (Kornitzer and Fink, unpublished
observations). We reasoned that, if Gcn4 is a direct substrate
of the Cdc34/SCFCDC4 complex, in mutant cells, where
Cdc34/SCFCDC4 activity is limiting, Gcn4 overexpression
may compete with the cell cycle substrates and lead to cell
cycle arrest even at the normally permissive temperature. To
test this, a Gcn4 construct under the strong galactose-induc-
ible GAL1–CYC1 hybrid promoter was expressed in wild-
type and mutant cells. As can be seen in Figure 4, at the
normally permissive temperature of 30°C, the presence of
the Gcn4-overexpressing plasmid led to complete growth
arrest of the cdc34-2 and cdc53-1 mutants on galactose me-
dium and to strong growth repression of the cdc4-1 mutant.
Microscopic observation of these cells showed the character-
istic multibudded phenotype of this class of cell division
cycle mutants (our unpublished observations). The fact that
overexpression of Gcn4 in these mutant backgrounds results
in a mutant phenotype at 30° that mimics the phenotype at
37° supports the assumption that Gcn4 is a direct substrate
of Cdc34/SCFCDC4 and that its overexpression competi-
tively inhibits the complex.
Starvation Does Not Affect Degradation of Other
SCF Substrates
Is Gcn4 ubiquitination regulated by modulation of Cdc34/
SCFCDC4 activity or by modification of the substrate, Gcn4?
If the Cdc34/SCFCDC4 complex were regulated, one would
predict that amino acid starvation would stabilize other
Figure 3. Gcn4 degradation is
inhibited in cdc53 and skp1 mu-
tants. Pulse–chase analysis of
Gcn4–-LacZ expressed from the
CUP1 promoter of plasmid KB449
in strains W303 and MTY740 (left)
or YPH1015, YPH1161, and
YPH1172 (right). The cultures
were shifted from 30 to 37°C, 30
min before labeling.
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substrates of this complex. To test this, two additional sub-
strates of the Cdc34/SCFCDC4 complex, the CDK inhibitor
Sic1 and Cdc6, a protein involved in initiation of DNA
replication, were analyzed for their stability. Sic1 degrada-
tion usually occurs at the end of G1 and is dependent upon
phosphorylation by Cln1 or -2/Cdc28 (Schneider et al., 1996;
Tyers, 1996; Verma et al., 1997). To dissociate the effects of
starvation on Sic1 degradation from effects on the cell cycle
progression, degradation was tested in S-phase–arrested
cells in which a stable version of Cln2 (Lanker et al., 1996)
was ectopically expressed from the GAL1 promoter. Sic1
was constitutively expressed from the CUP1 promoter. Un-
der these conditions, in rich medium, 90% of Sic1 was de-
graded in the first 10 min of the chase. The residual fraction
appeared to be stable (Figure 5A) and could represent the
Sic1 protein from a subpopulation of cells having lost the
toxic GAL–CLN2 plasmid. Cells starved for amino acids
display the same kinetics of Sic1 degradation, indicating that
starvation does not affect the ubiquitination of this protein
by the complex.
Cdc6 degradation is also cell cycle regulated and peaks in
late G1/early S (Drury et al., 1997). To measure Cdc6 deg-
radation, a Cdc6–LacZ fusion was placed under the control
of the GAL promoter, and degradation of the fusion protein
was assayed in cells arrested in G1 with a-factor. The half-
life of the Cdc6–lacZ fusion protein was 8 min in standard
synthetic medium; in cells shifted to starvation medium 30
min before the chase, the half-life increased approximately
twofold, to 15 min (Figure 5B). By comparison, in a parallel
experiment, using the same starvation regimen, the half-life
of Gcn4 increased from 3 to 21 min, i.e., sevenfold (Figure
5B). Thus, these results suggest that SCFCDC4 activity is not
regulated by amino acid starvation.
Identification of a Sequence in Gcn4 Responsive to
the Starvation Signal
If SCFCDC4 activity is constitutive, then the regulation of
Gcn4 degradation must occur at the level of substrate mod-
ification. To identify the sequence in Gcn4 that is the target
of this regulation, we tested a series of GCN4 deletions for
degradation under starvation versus nonstarvation condi-
tions. Previous deletion analysis identified an extended re-
gion of Gcn4, including at least residues 93–200, that is
required for degradation (Kornitzer et al., 1994). Finer dele-
tion mapping allowed us to subdivide that region in at least
two domains, extending from 93 to 118 (“I”) and from 140 to
200 (“II”). This subdivision is based on the observation that
a deletion of residues 118–140 barely affects stability of the
protein, whereas deletions N-terminal or C-terminal to these
residues (e.g., D151–167) significantly stabilize the protein
(Kornitzer et al., 1994; our unpublished results; Figure 6).
Figure 4. Effect of Gcn4 overexpression on the growth of various
SCF mutants. Plasmid KB496, expressing Gcn4 under the strong
GAL1–CYC1 hybrid promoter, or the vector plasmid pLGSD5, were
transformed into the indicated strains. The strains were streaked on
selective galactose plates and incubated for 3 d at 30°C.
Figure 5. Starvation does not af-
fect degradation of two other SCF-
CDC4 substrates. (A) Degradation
of Sic1. Cells carrying plasmids
KB733 (CUP1-SIC1) and pGAL1-
CLN2(4T3S)HA (Lanker et al.,
1996) were arrested in S-phase
with hydroxyurea, induced with
galactose to produce Cln2, and
subjected to pulse– chase analysis
without (SC) or with (SD) prior
amino acid starvation. The Sic1
protein was visualized by immu-
noprecipitation with a specific an-
tibody. The arrow on the right in-
dicates Sic1. (B) Degradation of
Cdc6 –LacZ versus Gcn4 –LacZ.
Cells carrying plasmid KB448
(pGAL1–CDC6 –LacZ) or KB64 (pGAL1–GCN4 –LacZ) were grown in galactose, arrested in G1 with a-factor, and subjected to
pulse– chase analysis without (SC) or with (SD) prior amino acid starvation (30 min in medium lacking amino acids). The lacZ fusion
proteins were visualized by immunoprecipitation with a specific LacZ antibody. The graph depicts the quantitation of the fusion protein
band by phosphorimager.
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Within domain I, point mutations at positions S101, T105,
and P106 were sufficient to partially stabilize the protein
(Kornitzer et al., 1994). If this degradation signal were the
only target modified in starved versus unstarved cells, then
mutations in that signal would render the degradation un-
responsive to starvation. However, we found that mutation
T105A was still stabilized further by starvation (our unpub-
lished results). Likewise, a protein lacking residues 93–140
was partially stabilized when compared with the full-length
protein but still stabilized further under starvation condi-
tions (Figure 6). In contrast, a deletion of residues 151–167
led also to partial stabilization of the protein in rich medium,
but it was not stabilized further upon starvation; in fact, its
half-life was somewhat reduced under starvation conditions
(Figure 6). Degradation of D(151–167) was tested in two
additional experiments and consistently found to be slightly
faster under starvation conditions (unpublished results).
Thus, deletion D(151–167) may define a sequence that is
differentially modified in sated versus starved cells.
Gcn4 Degradation Requires Pho85 Activity
It was reasonable to assume that Gcn4 might be modified by
phosphorylation because other known SCF substrates re-
quire phosphorylation by the main yeast cell cycle CDK,
Cdc28, before ubiquitination. Although Gcn4 degradation is
unaffected in cdc28-1 mutant cells even at the nonpermissive
temperature (Kornitzer and Fink, unpublished results), the
yeast genome contains four additional CDK homologues,
including Pho85, Kin28, and Srb10. An SRB10 null mutant,
srb10-3 (Liao et al., 1995), and a KIN28 temperature-sensitive
mutant, kin28-ts3 (Valay et al., 1993), were not defective in
Gcn4 degradation (unpublished results). We found, how-
ever, that PHO85 is required for Gcn4 degradation. Initially,
two observations suggested a genetic interaction between
PHO85 and GCN4. First, we found it impossible to transform
a pho85D strain with a plasmid carrying a constitutive GCN4
mutation (Hinnebusch, 1984). In addition, the pho85D mu-
tant was highly sensitive to overexpression of GCN4 under
the GAL promoter (unpublished results).
These genetic interactions led us to test Gcn4 degradation
in a pho85D mutant. As shown in Figure 7A, Gcn4 was
markedly, but not completely, stabilized in the pho85D
strain, with a half-life of 10 min instead of 2.5 min. In this
assay, we used a Gcn4–LacZ fusion overexpressed under a
heterologous promoter. To confirm that this stabilization
was not due to overexpression, we used antibodies against
Gcn4 to follow the degradation of the native, endogenous
protein. Although the expression of the endogenous protein
is weak, we were able to see a rapid degradation in the
PHO85 strain, and a strong stabilization in the pho85D strain
(Figure 7C). We also tested transcriptional activity of endog-
enous Gcn4 in the pho85D mutant, using as reporter an
HIS4–LacZ fusion exclusively dependent on Gcn4 for ex-
pression (Nagawa and Fink, 1985). HIS4 expression was
increased twofold in the mutant versus the wild-type strain,
indicating that the stabilization of Gcn4 was accompanied
by an increase in transcriptional activity (Figure 7D).
Identification of the Critical Pho85 Target Site on
Gcn4
CDK target sites are characterized by a serine or threonine
residue followed by a proline. Gcn4 contains five such sites,
at positions 17, 61, 105, 165, and 218. Previous deletion
analysis excluded positions 17, 61, and 218 from being re-
quired for Gcn4 degradation. Of the two remaining sites,
Thr105 had already been shown to be required for degrada-
tion (Kornitzer et al., 1994). However, the T105A mutant was
still stabilized further in PHO85 versus pho85D cells (Figure
7E), suggesting that Pho85 may target another site on Gcn4.
The last potential site, Thr165, is located in domain II, shown
by deletion analysis to be required for degradation, and for
the starvation response (see above, Figure 6). Strikingly,
Thr165 is embedded within a sequence, TPVL, which con-
forms to a proposed Pho85 target consensus sequence,
S/TPXI/L (O’Neill et al., 1996). To test the requirement of
Thr165 for Gcn4 degradation, the residue was subjected to
site-directed mutagenesis. Substitution of an alanine for
Thr165 resulted in strong stabilization of the protein (Figure
8A), with an increase in half-life from 5 to .30 min. In
addition, this mutant displayed a significant increase in
Gcn4-dependent transcriptional activity, as measured by
HIS4–LacZ activity (Figure 8B). The high initial stability of
this mutant precluded us from testing for further stabiliza-
tion upon starvation.
Phosphorylation of Thr165 in Vivo
To directly show Pho85-dependent phosphorylation of
Thr165 in vivo, we fused a fragment of Gcn4 extending from
residue 62 to residue 202 to a triple Myc epitope. This
fragment, although more stable than full-length Gcn4, is still
rapidly degraded (our unpublished results) and contains
fewer potential kinase target sites than the full-length pro-
Figure 6. Effect of deletions in Gcn4 on the sensitivity to starva-
tion. Full-length Gcn4 and two deletions fused to LacZ were sub-
jected to pulse–chase analysis without (SC) or with (SD) prior mild
starvation (15 min in medium lacking amino acids). Note the dif-
ference in time scale. t1⁄2 indicates the half-lives of the three proteins
under both conditions as derived from quantitation of the data by
phosphorimager. “DEGRADATION” denotes the minimal region of
Gcn4 required for degradation, and “I” and “II” indicate the two
domains of that region, as defined by deletion analysis (see text).
“DB-LZ” denotes the DNA binding domain and the leucine zipper
domain of Gcn4.
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tein. The epitope-tagged fragment was then expressed in
cells subjected to phosphate labeling and immunoprecipi-
tated. As shown in Figure 9, (lanes 1 and 5) the immuno-
precipitated phosphate-labeled protein migrated as two dis-
tinct bands, indicating that it still contained at least two
phosphorylation sites. However, the protein fragment car-
rying the T165A mutation migrated as the single faster-
migrating band only (lane 2), indicating that the slower-
migrating band represents phosphorylation at Thr165 (the
stronger signal of the mutant versus the wild-type protein
fragment reflects the fact that the mutant protein is more
stable). We then tested the phosphorylation pattern of Gcn4
in pho85D cells. Strikingly, the slower-migrating band was
absent in these cells (lane 3), indicating that one site, pre-
sumably Thr165, is underphosphorylated in the pho85D mu-
tant. We further tested phosphorylation of the 62–202 frag-
ment under conditions that stabilize Gcn4. As shown in
lanes 6 and 7, cycloheximide treatment or amino acid star-
vation also resulted in the disappearance of the slower-
migrating band, suggesting loss of phosphorylation at
Thr165 under these conditions.
Pho85 Phosphorylates Gcn4 in Vitro
The data shown above indicate that Gcn4 phosphorylation
on Thr165 depends on Pho85 activity in vivo. However, the
possibility still existed that this is an indirect effect and that
another kinase is directly responsible for Gcn4 phosphory-
lation. To show that Pho85 is able to directly phosphorylate
Gcn4, we first attempted to reconstitute the phosphorylation
reaction in vitro with pure recombinant proteins. Pho85, like
all CDKs, requires a regulatory cyclin subunit for its activity.
Pcl1 is one of the 10 different Pho85 cyclins (Pcls) identified
to date (Andrews and Measday, 1998). We used recombi-
nant GST-Pho85 together with GST-Pcl1 (Nishizawa et al.,
1998) to phosphorylate either full-length heptahistidine-
tagged Gcn4 or the same 62–202 fragment of Gcn4 used for
the in vivo phosphate labeling, fused to GST. As shown in
Figure 10, efficient phosphorylation of full-length Gcn4 de-
pended both on an active Pho85 kinase and on Pcl1. Fur-
thermore, phosphorylation of the wild-type 62–202 Gcn4
fragment fused to GST yielded two bands, but with the
mutant T165A construct only the lower band was evident,
indicating that Pho85 is able to phosphorylate Thr165 di-
rectly.
Finally, we asked whether cellular Pho85 and Pcl1 activity
toward Gcn4 was dependent on physiological conditions
favoring Gcn4 degradation. ha-tagged Pcl1 (Nishizawa et al.,
1998) was immunoprecipitated from untreated exponen-
tially growing cells, or from amino acid–starved or cyclo-
heximide-treated cells. As shown in Figure 11, kinase activ-
Figure 7. Degradation of Gcn4 in
pho85D cells. (A) Pulse–chase anal-
ysis of Gcn4–LacZ expressed from
the CUP1 promoter of plasmid
KB449 in W303 and DY4535 cells.
(B) Quantitation of the experiment
shown in (A). (C) Pulse–chase anal-
ysis of native, endogenous Gcn4 in
W303 and DY4535 cells. The lane
marked “C” indicates an extract
from a gcn4D strain. The anomalous
migration of native Gcn4 (shown
here) as well as of recombinant
Gcn4 (Figures 10 and 11), a 33-kDa
protein, has been noted before
(Hope and Struhl, 1985). Note that
a doublet of cross-reacting bands
migrates slightly slower than Gcn4.
(D) Expression of His4–LacZ from
a HIS4 promoter derivative that is
exclusively dependent on Gcn4 for
activity (deletion number 203; Na-
gawa and Fink, 1985) in W303 and
DY4535 cells. Overnight cultures
were diluted and grown for 6 h to
early log phase, and the b-galacto-
sidase activity of the cultures was
measured as described (Daignan-
Fornier and Fink, 1992). (E) Degra-
dation of the T105A mutant of Gcn4
in W303 and DY4535 cells.
Gcn4(T105A)-LacZ was expressed
from the GAL promoter of plasmid
KB358 (Kornitzer et al., 1994).
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ity toward both the full-length Gcn4 protein and the 62–202
fragment, was strongly reduced in the starved or cyclohex-
imide-treated cells. Thus, Pcl1-associated Gcn4 kinase activ-
ity correlated with the conditions under which Gcn4 is rap-
idly degraded.
DISCUSSION
The findings presented here begin to unravel the mechanism
by which Gcn4 degradation is regulated: a) inhibition of
protein synthesis, even in the absence of starvation, is suf-
ficient to stabilize Gcn4; b) the SCFCDC4 ubiquitination com-
plex is required for Gcn4 degradation, but its activity is not
affected by starvation; c) Gcn4 degradation requires the ac-
tivity of the cyclin-dependent kinase Pho85; d) a specific
domain of Gcn4 is required for its starvation-sensitive deg-
radation; e) a specific site within that region, Thr165, is
required for Gcn4 degradation; f) phosphorylation of this
site depends on Pho85 activity and correlates with the con-
ditions that allow rapid degradation of Gcn4; g) Pho85 is
able to phosphorylate Thr165; and h) Pho85 activity toward
Gcn4 is reduced in starved cells. The simple model emerging
from these results is that Gcn4 phosphorylation by Pho85 on
Thr165 transforms it into a substrate of the SCFCDC4 ubiq-
uitination complex (Figure 12). The differential degradation
of Gcn4 versus other SCFCDC4 substrates is explained by the
different kinases required to transform the proteins into
effective substrates of the ubiquitination complex. The reg-
ulation of Pho85 activity by starvation explains the stabili-
zation of Gcn4 under these conditions.
Recognition sites of the SCF complexes are ill defined,
beyond the general requirement for phosphorylation. Dele-
tion analysis allowed to define two separate domains, I and
II, within the region of Gcn4 required for its rapid degrada-
tion (Figure 7). We previously described a number of muta-
tions in and around position 105 that stabilize Gcn4 (Korni-
tzer et al., 1994). Thr105 is located in domain I. Thr165, which
we characterize in the present study, is located in domain II.
It is possible that these two residues constitute each the core
of partially redundant SCFCDC4 recognition sites. Phosphor-
ylation of the 62–202 fragment of Gcn4 (Figure 9), which
carries both sites, suggests that in vivo, Pho85 activity is
required for Thr165 phosphorylation but that phosphoryla-
tion of (an)other site(s) in this fragment, possibly Thr105,
does not require Pho85. Conversely, our in vitro phosphor-
ylation data (Figures 10 and 11) indicate that this same
fragment can be phosphorylated by Pho85 at Thr165 as well
as at another site, possibly Thr105. Thus, Pho85 activity is
necessary and sufficient only for phosphorylation of Thr165.
Interestingly, contrary to Nishizawa et al. (1998), who
found that recombinant Pho85-Pcl1 will phosphorylate Sic1
only after being “activated” with a yeast cell extract, we
found that phosphorylation of Gcn4 does not require such
an activation. Our results are in agreement with the recent
findings of Wilson et al. (1999), that Gsy2 is efficiently phos-
phorylated in vitro by recombinant Pho85-Pcl10. Thus, it is
possible that in the case of Sic1 phosphorylation, the cell
extract confers a specificity factor required for Sic1 recogni-
tion, rather than an activation factor.
The Thr165 mutation was not isolated in our previous
screen, probably because that screen depended on the en-
hanced transcriptional activity of Gcn4—the Thr105 muta-
tion yielded a 15-fold increase in transcriptional activity
Figure 8. A mutation at residue Thr165 stabilizes Gcn4. (A) Pulse–
chase analysis of wild-type (KB149) and mutant (KB854) Gcn4–LacZ
expressed from the GAL promoter in W303 cells. Note the difference
in time scale. (B) Expression of His4–LacZ from the full-length HIS4
promoter (plasmid pFN6; Nagawa and Fink, 1985). The strain used,
bas1-2 bas2-2 gcn4D1 (KY26), is defective in both HIS4 transcription
factors (Arndt et al., 1987). His4–LacZ expression is exclusively
dependent on the plasmid-borne GCN4 alleles expressed from the
ADE8 promoter of plasmids KB105 (WT) or KB853 (T165A). The
b-galactosidase assay was performed as for Figure 7D.
Figure 9. In vivo phosphorylation of a fragment of Gcn4 encom-
passing residues 62–202 fused to a triple Myc epitope and expressed
from the CUP1 promoter. The upper phosphorylation band (indi-
cated by an arrow) is 30–40% as intense as the lower band in lanes
1 and 5 and is undetectable in the other lanes, even upon prolonged
exposure (we estimate the limit of detection at ,2% of the main
band). Lane 4 is a no-tag control. CHX, cycloheximide treatment (1
mg/ml, 30 min); a.a. starv, 30-min incubation in YNB medium
lacking all amino acids.
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(Kornitzer et al., 1994), whereas the Thr165 mutation only
increased transcription 5-fold (Figure 8). Interestingly,
Thr105 lies within the region defined by deletion analysis as
the Gcn4 activation domain (Hope and Struhl, 1986; Hope et
al., 1988). More recent mutational mapping showed that the
activation domain can be subdivided into two redundant
subdomains, the N-terminal and central acidic activation
domains (Drysdale et al., 1995; Jackson et al., 1996). The
Thr105 region lies between these two subdomains. Thus, it is
possible that the mutations that were isolated in that region,
in addition to stabilizing the protein, increase its specific
transcriptional activity by modification of the activation re-
gion. In line with the recent findings of Komeili and O’Shea
(1999), showing that phosphorylation of the transcription
factor Pho4 by Pho85 affects its transcriptional activity, it is
conceivable that the role of phosphorylation at Thr105 is to
modulate the transcriptional activity of Gcn4 more than its
stability.
The main difference between the requirements of Gcn4
degradation compared with that of the cell cycle substrates
of SCF is the specific kinase involved. Gcn4 degradation
requires Pho85 activity, whereas the other known SCF sub-
strates require Cdc28 activity. The known functions of Pho85
in association with specific cyclins relate to metabolic regu-
lation, e.g., phosphate assimilation (cyclin: Pho80; Kaffman
et al., 1994), or glycogen synthesis (cyclins: Pcl8 and -10;
Huang et al., 1998). In this respect, a function in Gcn4 deg-
radation and therefore, indirectly, in amino acid metabo-
lism, fits this pattern. The fact that the degradation of the cell
cycle substrates of the SCFCDC4 complex depends on the
phase of the cell cycle, whereas Gcn4 degradation is consti-
tutive during the cell cycle, can be accounted for by differ-
ence in the kinase involved. Indeed, the nine Cdc28-associ-
ated cyclins, which confer its substrate specificity, are each
present only during a limited window of each cell cycle. In
contrast, most, but not all, of the 10 Pho85 cyclins are present
throughout the cell cycle (Andrews and Measday, 1998).
Strikingly however, Pcl1 is one of the Pho85 cyclins that is
strongly cell cycle regulated, at least at the level of transcrip-
tion (Measday et al., 1997). This apparent contradiction
would be resolved if different Pcls were able to promote
Gcn4 phosphorylation. Two observations indicate that this is
in fact the case: a) if Pcl1 were the only Pcl able to promote
Gcn4 phosphorylation, then Gcn4 should be stabilized in a
pcl1D mutant. However, a number of single and multiple
combinations of pcl mutants that we tested, including pcl1D,
are unaffected in Gcn4 degradation (our unpublished re-
sults); and b) preliminary data indicate that at least one other
Pcl, Pho80, is able to promote Gcn4 phosphorylation on
Thr165 by Pho85 in vitro (our unpublished results). These
two findings indicate that there may be a high redundancy
in the Pcls able to activate Pho85 for Gcn4 phosphorylation.
Figure 10. In vitro phosphorylation of Gcn4 by
Pho85-Pcl1. Different substrates (indicated at the
bottom) were incubated with wild-type or catalyti-
cally inactive (E53A) GST-Pho85, with or without
GST-Pcl1. Asterisk indicates background phosphor-
ylation on bacterial proteins copurifying with the
recombinant kinase and cyclin. The two arrowheads
indicate the two phosphorylation bands of GST-
Gcn462–202. The two weak signals (,10% intensity)
visible over the main band in the T165A mutant
presumably represent phosphorylation at alterna-
tive sites. The right panel shows that GST alone is
not phosphorylated by Pho85-Pcl1 (the GST protein
band would be expected to migrate slightly faster
than the 30-kDa marker).
Figure 11. In vitro phosphorylation of
Gcn4 by ha-Pcl1–associated kinase activ-
ity. Different substrates (indicated at the
bottom) were incubated with Protein A-
agarose beads carrying Pcl1-associated
kinase activity immunoprecipitated
from various cell extracts. pho85D indi-
cates that the extract was made from a
pho85 mutant strain; all other extracts
were from wild-type cells. starv. and
CHX refer to the same treatments as in
Figure 9. no Ab refers to a blank immu-
noprecipitation in the absence of anti-
body. The two arrowheads at the right
indicate the two phosphorylation bands
of the GST-Gcn462–202 substrate.
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How is Gcn4 phosphorylation by Pho85 regulated by
starvation? Starvation could induce an inhibitor of Pho85
activity. Previous studies demonstrated that inhibition of an
amino acyl-tRNA–charging enzyme also leads to Gcn4 sta-
bilization (Kornitzer et al., 1994), suggesting that uncharged
tRNA constitutes the signal for Gcn4 stabilization. An ele-
vated concentration of uncharged tRNA is also thought to
constitute the primary signal for the translational control of
Gcn4 (Wek et al., 1995). In the current study, we found that
inhibition of translation by cycloheximide is sufficient to
stabilize Gcn4. Under these conditions, charged rather than
uncharged tRNA accumulates in the cell. It should be noted
that this does not contradict the earlier results obtained with
the aminoacyl-tRNA–charging enzyme mutant; indeed, in-
hibition of one of the 20 aminoacyl tRNA synthetases, al-
though resulting in an increase in the concentration of the
uncharged form of its cognate tRNAs, would also, via inhi-
bition of translation, increase the concentration of the charged
form of all the other tRNAs. However, there is no direct
evidence that Pho85 activity is regulated by the charged
tRNA concentration or by any other signal generated by the
stalled cellular biosynthetic machinery. An alternative pos-
sibility is that continued protein synthesis per se is required
for maintaining Pho85 activity; therefore, starvation, or di-
rect inhibition of protein synthesis, would result in reduced
kinase activity.
Limitation of protein synthesis is known to arrest the cell
cycle in G1 (Unger and Hartwell, 1976; Shilo et al., 1978;
Pardee, 1989). The fact that the SCFCDC4 complex is required
for the G1/S transition and for Gcn4 turnover raised the
possibility that amino acid starvation coordinately inhibits
cell cycle progression and Gcn4 degradation via inhibition of
the SCFCDC4 complex (Kornitzer et al., 1994). However, our
data do not support this hypothesis. Cdc6 and Sic1, two
other substrates of the SCFCDC4 complex, are not stabilized
upon starvation. Rather, our data indicate that Gcn4 degra-
dation is regulated via modulation of Pho85 activity. Might
modulation of Pho85 activity coordinately regulate Gcn4
turnover and cell cycle progression? Recent reports indicate
a role for the G1 cyclin Cln3 in the cell cycle arrest in face of
reduced protein synthesis (Polymenis and Schmidt, 1997;
Danaie et al., 1999). However, it cannot be excluded that
modulation of Pho85 activity also participates in this regu-
lation. Pho85, although not essential for cell cycle progres-
sion, displays cell cycle–related phenotypes. For example, a
deletion of the Cdc28 cyclins CLN1 and CLN2 is syntheti-
cally lethal with a deletion of the Pho85 cyclins PCL1 and
PCL2 or of PHO85 itself (Espinoza et al., 1994; Measday et al.,
1994). Thus, it is possible that Pho85 is one of the transducers
of physiological signals, such as amino acid starvation, that
need to be integrated by the cell cycle machinery.
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